AIA Group Ltd raised its position in shares of Henry Schein, Inc. (NASDAQ:HSIC – Get Rating) by 32.9% during the first quarter, HoldingsChannel reports. The firm owned 2,304 shares of the company’s stock after purchasing an additional 571 shares during the period. AIA Group Ltd’s holdings in Henry Schein were worth $201,000 at the end of the most recent reporting period.
Other large investors have also recently modified their holdings of the company. Covestor Ltd bought a new position in Henry Schein during the 4th quarter worth approximately $35,000. National Bank of Canada FI purchased a new stake in shares of Henry Schein during the fourth quarter valued at approximately $42,000. Quent Capital LLC purchased a new stake in shares of Henry Schein during the fourth quarter valued at approximately $47,000. Dupont Capital Management Corp boosted its stake in shares of Henry Schein by 46.2% during the first quarter. Dupont Capital Management Corp now owns 611 shares of the company’s stock valued at $53,000 after purchasing an additional 193 shares during the period. Finally, Hazlett Burt & Watson Inc. purchased a new stake in shares of Henry Schein during the first quarter valued at approximately $89,000. Hedge funds and other institutional investors own 94.30% of the company’s stock.
Insider Buying and Selling at Henry Schein
In other Henry Schein news, EVP Gerald A. Benjamin sold 11,489 shares of the firm’s stock in a transaction on Thursday, May 26th. The stock was sold at an average price of $85.47, for a total transaction of $981,964.83. Following the completion of the transaction, the executive vice president now owns 95,616 shares of the company’s stock, valued at $8,172,299.52. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.00% of the company’s stock.
Henry Schein Stock Performance
Henry Schein (NASDAQ:HSIC – Get Rating) last announced its quarterly earnings data on Tuesday, August 2nd. The company reported $1.16 EPS for the quarter, meeting the consensus estimate of $1.16. The business had revenue of $3.03 billion during the quarter, compared to analyst estimates of $3.12 billion. Henry Schein had a return on equity of 15.56% and a net margin of 5.11%. The company’s revenue for the quarter was up 2.1% on a year-over-year basis. During the same quarter last year, the firm posted $1.11 earnings per share. On average, equities analysts forecast that Henry Schein, Inc. will post 4.85 earnings per share for the current fiscal year.
Analyst Ratings Changes
HSIC has been the subject of a number of analyst reports. Stifel Nicolaus dropped their price objective on Henry Schein from $90.00 to $80.00 in a research note on Friday, June 17th. Credit Suisse Group dropped their price objective on Henry Schein from $100.00 to $90.00 and set an “outperform” rating for the company in a research note on Wednesday. William Blair reissued a “market perform” rating on shares of Henry Schein in a research note on Tuesday, May 3rd. StockNews.com lowered Henry Schein from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, July 19th. Finally, Barrington Research dropped their price target on Henry Schein from $102.00 to $99.00 and set an “outperform” rating for the company in a research note on Wednesday. One research analyst has rated the stock with a sell rating, three have given a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat, Henry Schein currently has an average rating of “Hold” and a consensus target price of $87.14.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
- Get a free copy of the StockNews.com research report on Henry Schein (HSIC)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc’s Revenues Are Up, Is It Time to Buy?
- Beyond Meat Is Not Beyond Hope, And It’s Cheap
- Why Apple Could Be At All-Time Highs By Year End
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.